{ "cik": 1711279, "cik_padded": "0001711279", "entityName": "Krystal Biotech, Inc.", "fiscal_years": [ { "accn": "0001711279-26-000016", "filed": "2026-02-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11951000.0, "cash": 496304000.0, "eps_diluted": 6.84, "free_cash_flow": 188914000.0, "net_income": 204831000.0, "operating_cash_flow": 200865000.0, "operating_income": 161295000.0, "revenue": 389130000.0, "stockholders_equity": 1219560000.0, "total_assets": 1333794000.0, "total_liabilities": 114234000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09366820820623832, "net_margin": 0.5263819289183563, "operating_margin": 0.4145015804486933, "revenue_growth_yoy": 0.33944890969485225, "roa_avg2y": 0.1714330909529166, "roa_period_end": 0.15357019149883716, "roe_avg2y": 0.18913820327432893, "roe_period_end": 0.16795483617042212 } }, { "accn": "0001711279-26-000016", "filed": "2026-02-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4238000.0, "cash": 344865000.0, "eps_diluted": 3.0, "free_cash_flow": 119182000.0, "net_income": 89159000.0, "operating_cash_flow": 123420000.0, "operating_income": 65748000.0, "revenue": 290515000.0, "stockholders_equity": 946380000.0, "total_assets": 1055838000.0, "total_liabilities": 109458000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11565967159069296, "net_margin": 0.30689981584427656, "operating_margin": 0.22631533655749272, "revenue_growth_yoy": 4.730191917000336, "roa_avg2y": 0.09514388326068873, "roa_period_end": 0.084443825662649, "roe_avg2y": 0.10337149518759482, "roe_period_end": 0.09421057080665272 } }, { "accn": "0001711279-26-000016", "filed": "2026-02-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11799000.0, "cash": 358328000.0, "eps_diluted": 0.39, "free_cash_flow": -100603000.0, "net_income": 10932000.0, "operating_cash_flow": -88804000.0, "operating_income": -109617000.0, "revenue": 50699000.0, "stockholders_equity": 778641000.0, "total_assets": 818355000.0, "total_liabilities": 39714000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05100424971199821, "net_margin": 0.21562555474466952, "roa_avg2y": 0.015880244479065664, "roa_period_end": 0.01335850578294261, "roe_avg2y": 0.01680718779403354, "roe_period_end": 0.014039846347674988 } }, { "accn": "0001711279-26-000016", "filed": "2026-02-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 52979000.0, "cash": 161900000.0, "eps_diluted": -5.49, "free_cash_flow": -153548000.0, "net_income": -139975000.0, "operating_cash_flow": -100569000.0, "operating_income": -145196000.0, "stockholders_equity": 522231000.0, "total_assets": 558450000.0, "total_liabilities": 36219000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06935436617129201, "roa_avg2y": -0.2362955741530878, "roa_period_end": -0.25064911809472645, "roe_avg2y": -0.25089464396620564, "roe_period_end": -0.2680327288115795 } }, { "accn": "0001711279-25-000008", "filed": "2025-02-19", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 68336000.0, "cash": 341246000.0, "eps_diluted": -3.13, "free_cash_flow": -116274000.0, "net_income": -69570000.0, "operating_cash_flow": -47938000.0, "operating_income": -68275000.0, "stockholders_equity": 593576000.0, "total_assets": 626295000.0, "total_liabilities": 32719000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05512183781015405, "roa_avg2y": -0.1484731720694582, "roa_period_end": -0.11108183843077145, "roe_avg2y": -0.1571031772915114, "roe_period_end": -0.11720487351240616 } }, { "accn": "0001711279-24-000005", "filed": "2024-02-26", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14843000.0, "cash": 268269000.0, "eps_diluted": -1.71, "free_cash_flow": -40926000.0, "net_income": -32167000.0, "operating_cash_flow": -26083000.0, "operating_income": -32999000.0, "stockholders_equity": 292084000.0, "total_assets": 310844000.0, "total_liabilities": 18760000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06422809876610838, "roa_avg2y": -0.12375088243723875, "roa_period_end": -0.10348277592618806, "roe_avg2y": -0.1299682018917248, "roe_period_end": -0.11012927787896633 } }, { "accn": "0001711279-23-000008", "filed": "2023-02-27", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6399000.0, "cash": 187514000.0, "free_cash_flow": -25089000.0, "net_income": -19088000.0, "operating_cash_flow": -18690000.0, "operating_income": -22081000.0, "stockholders_equity": 202914000.0, "total_assets": 209023000.0, "total_liabilities": 6109000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.030106350473599653, "roa_avg2y": -0.11741439814971442, "roa_period_end": -0.09132009396095167, "roe_avg2y": -0.12075662681090656, "roe_period_end": -0.09406940871502213 } }, { "accn": "0001711279-21-000006", "filed": "2021-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2234000.0, "cash": 103670000.0, "free_cash_flow": -11679000.0, "net_income": -10889000.0, "operating_cash_flow": -9445000.0, "operating_income": -11916000.0, "stockholders_equity": 113226000.0, "total_assets": 116116000.0, "total_liabilities": 2890000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.025524172893151748, "roa_avg2y": -0.1310112494736209, "roa_period_end": -0.09377691274242998, "roe_avg2y": -0.1338537185003073, "roe_period_end": -0.09617049087665377 } }, { "accn": "0001564590-20-009550", "filed": "2020-03-10", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 210000.0, "cash": 49591000.0, "net_income": -7920000.0, "operating_income": -4772000.0, "stockholders_equity": 49474000.0, "total_assets": 50114000.0, "total_liabilities": 640000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.012936087641993775, "roa_avg2y": -0.30289123451124367, "roa_period_end": -0.1580396695534182, "roe_avg2y": -0.31830878363442716, "roe_period_end": -0.16008408456967296 } }, { "accn": "0001564590-18-005252", "filed": "2018-03-12", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 15000.0, "cash": 1923000.0, "net_income": -1150000.0, "operating_income": -1143000.0, "stockholders_equity": 289000.0, "total_assets": 2182000.0, "total_liabilities": 1893000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 6.550173010380623, "roa_period_end": -0.5270394133822182, "roe_period_end": -3.9792387543252596 } } ], "latest_filing": { "accn": "0001711279-26-000016", "filed": "2026-02-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001711279.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001711279.json" }, "ticker": "KRYS" }